KLF6 and metabolic dysfunction-associated steatotic liver disease: Studies in murine hepatocytes indicate that KLF6 binds to the promoter of Glucokinase (Gck) and increases its expression, leading to hepatic insulin resistance and the development of non-alcoholic fatty liver disease (NAFLD) [54].